James E. Flynn 13D and 13G filings for Terns Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-10-04 5:09 pm Sale | 2023-10-04 | 13G | Terns Pharmaceuticals, Inc. TERN | James E. Flynn | 0 0.000% | -2,851,287 (Position Closed) | Filing |
| 2023-02-10 3:57 pm Unchanged | 2022-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN | James E. Flynn | 2,851,287 5.760% | 0 (Unchanged) | Filing |
| 2022-12-23 3:35 pm Purchase | 2022-12-23 | 13G | Terns Pharmaceuticals, Inc. TERN | James E. Flynn | 2,851,287 5.940% | 991,287 (+53.30%) | Filing |
| 2022-08-16 5:20 pm Sale | 2022-08-16 | 13G | Terns Pharmaceuticals, Inc. TERN | James E. Flynn | 1,860,000 4.940% | -485,959 (-20.71%) | Filing |
| 2022-02-11 4:15 pm Sale | 2021-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN | James E. Flynn | 2,345,959 9.280% | -36,074 (-1.51%) | Filing |
| 2021-02-09 2:21 pm Purchase | 2021-02-09 | 13G | Terns Pharmaceuticals, Inc. TERN | James E. Flynn | 2,382,033 9.940% | 2,382,033 (New Position) | Filing |